Association of thioredoxin reductase 2 (TXNRD2) gene polymorphisms with myocardial infarction in Slovene patients with type 2 diabetes mellitus

Brunetti, 2014, Recent advances in the molecular genetics of type 2 diabetes mellitus, World J Diabetes, 5, 128, 10.4239/wjd.v5.i2.128 Moreno, 2004, New aspects in the pathogenesis of diabetic atherothrombosis, J Am Coll Cardiol, 44, 2293, 10.1016/j.jacc.2004.07.060 Grundy, 1999, Diabetes and cardiovascular disease: a statement for healthcare professionals from the American Heart Association, Circulation, 100, 1134, 10.1161/01.CIR.100.10.1134 Brownlee, 2005, The pathobiology of diabetic complications: a unifying mechanism, Diabetes, 54, 1615, 10.2337/diabetes.54.6.1615 Giacco, 2010, Oxidative stress and diabetic complications, Circ Res, 107, 1058, 10.1161/CIRCRESAHA.110.223545 Kaneto, 2010, Role of reactive oxygen species in the progression of type 2 diabetes and atherosclerosis, Mediators Inflamm, 2010, 453892, 10.1155/2010/453892 Aon, 2012, Glutathione/thioredoxin systems modulate mitochondrial H2O2 emission: an experimental-computational study, J Gen Physiol, 139, 479, 10.1085/jgp.201210772 Schulze, 2004, Hyperglycemia promotes oxidative stress through inhibition of thioredoxin function by thioredoxin-interacting protein, J Biol Chem, 279, 30369, 10.1074/jbc.M400549200 Zhang, 2007, Endothelial-specific expression of mitochondrial thioredoxin improves endothelial cell function and reduces atherosclerotic lesions, Am J Pathol, 170, 1108, 10.2353/ajpath.2007.060960 Horstkotte, 2011, Mitochondrial thioredoxin reductase is essential for early postischemic myocardial protection, Circulation, 124, 2892, 10.1161/CIRCULATIONAHA.111.059253 Miranda-Vizuete, 1999, Human mitochondrial thioredoxin reductase cDNA cloning, expression and genomic organization, Eur J Biochem, 261, 405, 10.1046/j.1432-1327.1999.00286.x Meplan, 2012, Polymorphisms in thioredoxin reductase and selenoprotein K genes and selenium status modulate risk of prostate cancer, PLoS ONE, 7, e48709, 10.1371/journal.pone.0048709 Wang, 2008, Association of genetic polymorphisms in selenoprotein GPX1 and TXNRD2 with genetic susceptibility of gastric cancer, Zhonghua Yu Fang Yi Xue Za Zhi, 42, 511 Slattery, 2012, Genetic variation in selenoprotein genes, lifestyle, and risk of colon and rectal cancer, PLoS ONE, 7, e37312, 10.1371/journal.pone.0037312 Edvardsen, 2013, SNP in TXNRD2 associated with radiation-induced fibrosis: a study of genetic variation in reactive oxygen species metabolism and signaling, Int J Radiat Oncol Biol Phys, 86, 791, 10.1016/j.ijrobp.2013.02.025 Sibbing, 2011, Mutations in the mitochondrial thioredoxin reductase gene TXNRD2 cause dilated cardiomyopathy, Eur Heart J, 32, 1121, 10.1093/eurheartj/ehq507 Prasad, 2014, Thioredoxin reductase 2 (TXNRD2) mutation associated with familial glucocorticoid deficiency (FGD), J Clin Endocrinol Metab, 99, E1556, 10.1210/jc.2013-3844 Banerjee, 2014, Reactive metabolites and antioxidant gene polymorphisms in type 2 diabetes mellitus, Indian J Hum Genet, 20, 10, 10.4103/0971-6866.132747 Kariž, 2012, Association of manganese superoxide dismutase and glutathione S-transferases genotypes with myocardial infarction in patients with type 2 diabetes mellitus, Diabetes Res Clin Pract, 98, 144, 10.1016/j.diabres.2012.07.003 Katakami, 2010, Accumulation of gene polymorphisms related to oxidative stress is associated with myocardial infarction in Japanese type 2 diabetic patients, Atherosclerosis, 212, 534, 10.1016/j.atherosclerosis.2010.06.010 Expert Committee on the Diagnosis and Classification of Diabetes Mellitus, 2003, Report of the expert committee on the diagnosis and classification of diabetes mellitus, Diabetes Care, 26, S5, 10.2337/diacare.26.2007.S5 Alpert, 2000, Myocardial infarction redefined—a consensus document of The Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction, JACC, 36, 959, 10.1016/S0735-1097(00)00804-4 Flekac, 2008, Gene polymorphisms of superoxide dismutases and catalase in diabetes mellitus, BMC Med Genet, 9, 30, 10.1186/1471-2350-9-30 dos Santos, 2006, The catalase—262C/T promoter polymorphism and diabetic complications in Caucasians with type 2 diabetes, Dis Markers, 22, 355, 10.1155/2006/983408 Nakanishi, 2008, Manganese superoxide dismutase Ala16Val polymorphism is associated with the development of type 2 diabetes in Japanese–Americans, Diabetes Res Clin Pract, 81, 381, 10.1016/j.diabres.2008.06.003 Jones, 2010, Association between the rs4880 superoxide dismutase 2 (C>T) gene variant and coronary heart disease in diabetes mellitus, Diabetes Res Clin Pract, 90, 196, 10.1016/j.diabres.2010.07.009 Yoshihara, 2014, Thioredoxin/Txnip: redoxisome, as a redox switch for the pathogenesis of diseases, Front Immunol, 4, 514, 10.3389/fimmu.2013.00514 Dunn, 2010, The emerging role of the thioredoxin system in angiogenesis, Arterioscler Thromb Vasc Biol, 30, 2089, 10.1161/ATVBAHA.110.209643 Saxena, 2010, Intracellular shuttling and mitochondrial function of thioredoxin-interacting protein, J Biol Chem, 285, 3997, 10.1074/jbc.M109.034421 Minn, 2005, Thioredoxin-interacting protein is stimulated by glucose through a carbohydrate response element and induces beta-cell apoptosis, Endocrinology, 146, 2397, 10.1210/en.2004-1378 Kizhakekuttu, 2012, Adverse alterations in mitochondrial function contribute to type 2 diabetes mellitus-related endothelial dysfunction in humans, Arterioscler Thromb Vasc Biol, 32, 2531, 10.1161/ATVBAHA.112.256024 Liang, 2007, Thiol-related genes in diabetic complications: a novel protective role for endogenous thioredoxin 2, Arterioscler Thromb Vasc Biol, 27, 77, 10.1161/01.ATV.0000251006.54632.bb Zhao, 2014, Variations of thioredoxin system contributes to increased susceptibility to apoptosis in cardiomyocytes of type 2 diabetic rats, Acta Biochim Biophys Sin (Shanghai), 46, 318, 10.1093/abbs/gmu006 Dai, 2009, Endothelial-specific expression of mitochondrial thioredoxin promotes ischemia-mediated arteriogenesis and angiogenesis, Arterioscler Thromb Vasc Biol, 29, 495, 10.1161/ATVBAHA.108.180349 Widder, 2009, Attenuation of angiotensin II-induced vascular dysfunction and hypertension by overexpression of Thioredoxin 2, Hypertension, 54, 338, 10.1161/HYPERTENSIONAHA.108.127928 Arner, 2000, Physiological functions of thioredoxin and thioredoxin reductase, Eur J Biochem, 267, 6102, 10.1046/j.1432-1327.2000.01701.x Berndt, 2007, Thiol-based mechanisms of the thioredoxin and glutaredoxin systems: implications for diseases in the cardiovascular system, Am J Physiol Heart Circ Physiol, 292, H1227, 10.1152/ajpheart.01162.2006 Arner, 2009, Focus on mammalian thioredoxin reductases—important selenoproteins with versatile functions, Biochim Biophys Acta, 1790, 495, 10.1016/j.bbagen.2009.01.014 Conrad, 2004, Essential role for mitochondrial thioredoxin reductase in hematopoiesis, heart development, and heart function, Mol Cell Biol, 24, 9414, 10.1128/MCB.24.21.9414-9423.2004 He, 2008, Identification of thioredoxin-2 as a regulator of the mitochondrial permeability transition, Toxicol Sci, 105, 44, 10.1093/toxsci/kfn116 Bacci, 2002, Screening for silent myocardial ischaemia in type 2 diabetic patients with additional atherogenic risk factors: applicability and accuracy of the exercise stress test, Eur J Endocrinol, 147, 649, 10.1530/eje.0.1470649